Products with Osteogenic agents bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN1340 | 2,3,5,4'-Tetrahydroxyl diphenylethylene-2-O-glucoside |
| 2,3,5,4'-Tetrahydroxyldiphenylethylene-2-O-glucoside(TSG) has potential to the prevention and treatment of Alzheimer's diseases, it not only prevents over-expression of α-synuclein at an early stage, but also reverses the increased expression of α-synuclein and inhibits the aggregation at the late stage of Tg mice. TSG suppresses PDGF-BB-induced PASMCs proliferation is associated with an inhibition of AKT / GSK3β signaling pathways. TGS, emodin and physcion also have the lipid regulation activity to an overall synergy. | |
